Nifty

:

24363.30

Sensex

:

79857.79

-232.85 (-0.95%)
-765.47 (-0.95%)

Login

Nifty
Sensex

:
:

24363.30
79857.79

-232.85 (-0.95%)
-765.47 (-0.95%)

Alivus Life Sciences Ltd.

Pharmaceuticals & Drugs

Rating :

66/99

BSE: 543322 | NSE: ALIVUS

Watchlist

NSE BSE

934.80

08-Aug-2025

Open
High
Low
Previous Close

937.4
947.8
925.1
936.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

195379
182498430
1335.1
850

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

11,430.83
23.06
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

11,359.60
0.54%
3.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
8.23
2.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.39
1.82

PAT CAGR (%)

10 Years
5 Years
3 Years

-
8.50
3.99

P:E (Median)

8 Years
5 Years
3 Years

-
-
18.35

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
13.25

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 38.43 39.63 45.47 53.92
P/E Ratio 24.32 23.59 20.56 17.34
Revenue 2283 2387 2660 3053
EBITDA 674 683 791 939
Net Income 471 486 557 661
ROA 17 15.5 17.4 19
P/B Ratio 4.91 4.07 3.63 3.12
ROE 21.07 18.86 18.37 19
FCFF 297 243 184 307
FCFF Yield 2.35 1.92 1.45 2.43
Net Debt -284 -492 20 -98
BVPS 190.35 229.75 257.83 299.55

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 601.85 588.62 2.25% 649.54 536.60 21.05% 641.84 572.80 12.05% 506.88 595.36 -14.86%
Expenses 429.54 429.13 0.10% 451.11 395.15 14.16% 451.54 400.25 12.81% 372.52 428.28 -13.02%
EBITDA 172.31 159.48 8.04% 198.43 141.45 40.28% 190.31 172.56 10.29% 134.36 167.08 -19.58%
EBIDTM 28.63% 27.09% 30.55% 26.36% 29.65% 30.12% 26.51% 28.06%
Other Income 8.98 5.49 63.57% 10.09 3.13 222.36% 10.46 1.69 518.93% 8.53 5.37 58.85%
Interest 1.25 0.35 257.14% 1.26 0.36 250.00% 0.46 0.39 17.95% 0.34 0.40 -15.00%
Depreciation 17.06 14.39 18.55% 15.97 14.53 9.91% 15.16 13.18 15.02% 15.09 13.13 14.93%
PBT 162.98 150.24 8.48% 191.29 129.68 47.51% 185.15 160.68 15.23% 127.46 158.93 -19.80%
Tax 41.45 38.76 6.94% 49.42 31.74 55.70% 48.19 41.92 14.96% 32.14 40.19 -20.03%
PAT 121.53 111.48 9.02% 141.87 97.94 44.85% 136.96 118.77 15.32% 95.32 118.74 -19.72%
PATM 20.19% 18.94% 21.84% 18.25% 21.34% 20.73% 18.80% 19.94%
EPS 9.91 9.09 9.02% 11.57 7.99 44.81% 11.17 9.69 15.27% 7.77 9.68 -19.73%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 2,400.11 2,283.21 2,161.22 2,123.21 1,885.16 1,537.31 886.42 0.25 Net Sales Growth 4.65% 5.64% 1.79% 12.63% 22.63% 73.43% 354468.00% Cost Of Goods Sold 1,063.44 968.64 984.12 1,019.28 877.46 664.02 331.97 0.05 Gross Profit 1,336.67 1,314.58 1,177.10 1,103.93 1,007.70 873.29 554.45 0.20 GP Margin 55.69% 57.58% 54.46% 51.99% 53.45% 56.81% 62.55% 80.0% Total Expenditure 1,704.71 1,608.97 1,518.93 1,507.15 1,294.09 1,065.35 639.25 0.26 Power & Fuel Cost - 112.46 115.60 100.92 74.19 76.75 57.81 0.00 % Of Sales - 4.93% 5.35% 4.75% 3.94% 4.99% 6.52% 0% Employee Cost - 258.16 180.18 168.72 149.13 142.28 106.28 0.15 % Of Sales - 11.31% 8.34% 7.95% 7.91% 9.26% 11.99% 60.0% Manufacturing Exp. - 163.63 137.17 124.04 107.61 108.03 77.23 0.04 % Of Sales - 7.17% 6.35% 5.84% 5.71% 7.03% 8.71% 16.00% General & Admin Exp. - 55.14 46.45 54.18 43.36 44.09 29.51 0.02 % Of Sales - 2.42% 2.15% 2.55% 2.30% 2.87% 3.33% 8.00% Selling & Distn. Exp. - 38.52 45.10 31.78 33.79 26.32 27.91 0.00 % Of Sales - 1.69% 2.09% 1.50% 1.79% 1.71% 3.15% 0% Miscellaneous Exp. - 12.41 10.30 8.23 8.54 3.86 8.53 0.00 % Of Sales - 0.54% 0.48% 0.39% 0.45% 0.25% 0.96% 0% EBITDA 695.41 674.24 642.29 616.06 591.07 471.96 247.17 -0.01 EBITDA Margin 28.97% 29.53% 29.72% 29.02% 31.35% 30.70% 27.88% -4.00% Other Income 38.06 12.04 28.96 14.70 0.81 11.99 0.99 0.00 Interest 3.31 1.55 0.55 27.96 87.55 33.52 0.61 0.00 Depreciation 63.28 53.45 42.09 37.88 33.39 29.37 19.26 0.00 PBT 666.88 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Tax 171.20 160.40 161.65 146.20 119.36 107.97 32.70 0.42 Tax Rate 25.67% 25.41% 25.72% 25.88% 25.35% 25.64% 14.32% -4200.00% PAT 495.68 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 PAT before Minority Interest 495.68 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.65% 20.62% 21.61% 19.72% 18.65% 20.37% 22.07% -172.00% PAT Growth 10.91% 0.84% 11.52% 19.10% 12.29% 60.08% - EPS 40.43 38.41 38.09 34.15 28.68 25.54 15.95 -0.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 2,332.32 2,138.21 2,054.31 752.75 401.69 88.13 -1.40 Share Capital 24.50 24.50 24.50 1.96 1.96 1.96 0.01 Total Reserves 2,296.76 2,107.02 2,026.31 750.79 399.73 86.17 -1.41 Non-Current Liabilities 756.95 67.40 32.70 22.89 16.45 6.86 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 693.40 7.87 0.00 0.00 0.00 0.00 0.00 Current Liabilities 438.77 1,014.89 746.80 1,444.93 1,307.46 1,380.41 1.48 Trade Payables 368.66 427.23 307.72 221.31 201.07 182.89 0.01 Other Current Liabilities 58.08 54.57 49.84 966.54 1,084.03 1,181.11 1.46 Short Term Borrowings 0.00 0.00 0.00 0.00 0.02 0.02 0.00 Short Term Provisions 12.03 533.09 389.24 257.08 22.34 16.40 0.01 Total Liabilities 3,528.04 3,220.50 2,833.81 2,220.57 1,725.60 1,475.40 0.08 Net Block 805.06 780.63 589.76 572.80 546.25 456.31 0.00 Gross Block 1,012.33 936.48 705.53 651.90 594.82 475.57 0.00 Accumulated Depreciation 207.26 155.85 115.77 79.10 48.58 19.26 0.00 Non Current Assets 1,612.05 851.81 706.42 598.03 565.49 544.70 0.00 Capital Work in Progress 105.99 61.62 96.95 14.10 10.73 80.39 0.00 Non Current Investment 0.08 0.08 0.08 0.08 0.08 0.08 0.00 Long Term Loans & Adv. 700.92 9.49 19.63 11.06 8.44 7.92 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,916.00 2,368.68 2,127.39 1,622.53 1,160.11 930.70 0.08 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 666.59 604.17 516.24 513.42 412.77 400.84 0.04 Sundry Debtors 765.43 806.77 673.49 619.50 638.63 448.09 0.03 Cash & Bank 301.59 309.40 512.16 115.60 10.00 2.06 0.01 Other Current Assets 182.38 71.72 5.96 70.31 98.71 79.70 0.01 Short Term Loans & Adv. 90.69 576.63 419.54 303.70 65.00 18.04 0.01 Net Current Assets 1,477.23 1,353.80 1,380.59 177.60 -147.35 -449.72 -1.40 Total Assets 3,528.05 3,220.49 2,833.81 2,220.56 1,725.60 1,475.40 0.08

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 413.51 306.01 597.59 388.11 195.01 10.35 -0.48 PBT 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Adjustment 79.27 44.62 70.99 133.31 56.74 -101.15 0.00 Changes in Working Capital -134.08 -213.66 99.84 -107.58 -190.26 -93.26 -0.47 Cash after chg. in Working capital 576.48 459.57 735.75 496.68 287.54 33.89 -0.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -162.96 -153.56 -138.17 -108.56 -92.54 -23.54 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -116.48 -146.75 -122.23 -68.73 -50.52 -8.91 0.00 Net Fixed Assets -120.22 -195.62 -136.48 -60.45 -49.59 -555.96 Net Investments 0.00 0.00 0.00 0.00 0.00 -0.08 Others 3.74 48.87 14.25 -8.28 -0.93 547.13 Cash from Financing Activity -279.44 -387.59 -78.80 -213.78 -136.55 0.54 0.49 Net Cash Inflow / Outflow 17.59 -228.33 396.56 105.60 7.94 1.97 0.01 Opening Cash & Equivalents 283.82 512.16 115.60 10.00 2.06 0.01 0.00 Closing Cash & Equivalent 301.41 283.82 512.16 115.60 10.00 2.06 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 189.45 173.97 167.38 69.83 37.26 449.62 -1398.00 ROA 13.96% 15.43% 16.57% 17.82% 19.56% 26.51% -510.59% ROE 21.15% 22.33% 29.87% 60.91% 127.84% 451.05% 0.00% ROCE 28.31% 30.01% 42.24% 96.75% 185.60% 527.74% 0.00% Fixed Asset Turnover 2.35 2.65 3.13 3.03 2.88 3.73 248.00 Receivable days 125.30 124.34 111.01 121.50 128.84 92.26 45.63 Inventory Days 101.28 94.11 88.40 89.45 96.46 82.54 55.93 Payable days 149.95 136.29 94.72 87.85 65.75 52.18 24.84 Cash Conversion Cycle 76.63 82.16 104.69 123.10 159.54 122.62 76.71 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 409.34 1150.19 21.20 6.38 13.56 378.35 0.00

Top Investors:

polar capital funds plc - healthcare opportunities

quant mutual fund - quant small cap fund

massachusetts institute of technology

Annual Reports:

News Update:

Alivus Life Sciences - Quarterly Results
1st Aug 2025, 18:31 PM

Read More
USFDA issues EIR with NAI classification for Alivus Life Sciences’ API unit
28th Jul 2025, 11:53 AM

The USFDA had conducted an inspection from May 26, 2025 to May 30, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback